We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.25B
AUM Growth
+$91M
Cap. Flow
-$180M
Cap. Flow %
-5.53%
Top 10 Hldgs %
17.1%
Holding
462
New
59
Increased
82
Reduced
124
Closed
93

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$36.3M
2
UNP icon
Union Pacific
UNP
+$36.1M
3
PVH icon
PVH
PVH
+$31.6M
4
NOW icon
ServiceNow
NOW
+$26.6M
5
AAPL icon
Apple
AAPL
+$24.8M

Sector Composition

Rank Sector Weight
1 Healthcare 20.46%
2 Technology 16.19%
3 Consumer Discretionary 12.93%
4 Financials 12.58%
5 Industrials 12.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOW icon
26
ServiceNow
NOW
$118B
$27.3M 0.84%
791,850
+768,850
+3,343% +$26.6M
EW icon
27
Edwards Lifesciences
EW
$48.9B
$25.8M 0.79%
532,191
+522,621
+5,461% +$24.4M
EOG icon
28
EOG Resources
EOG
$77.6B
$25.8M 0.79%
206,969
-165,891
-44% -$19.3M
URI icon
29
United Rentals
URI
$67B
$25.4M 0.78%
172,285
-44,095
-20% -$7.2M
GOOG icon
30
Alphabet (Google) Class C
GOOG
$4.06T
$25.3M 0.78%
453,580
-5,000
-1% -$270K
ATVI
31
DELISTED
Activision Blizzard
ATVI
$25M 0.77%
327,897
+243,275
+287% +$17.2M
HD icon
32
Home Depot
HD
$337B
$24.9M 0.77%
127,698
-92,115
-42% -$17.2M
AMAT icon
33
Applied Materials
AMAT
$358B
$22.4M 0.69%
484,888
-283,243
-37% -$14.6M
ADBE icon
34
Adobe
ADBE
$104B
$21.4M 0.66%
87,849
+44,147
+101% +$10.4M
ICUI icon
35
ICU Medical
ICUI
$4.14B
$20.4M 0.63%
69,340
-1,972
-3% -$539K
HAE icon
36
Haemonetics
HAE
$3.81B
$20.3M 0.63%
226,602
-7,754
-3% -$655K
CZR icon
37
Caesars Entertainment
CZR
$6.06B
$19.5M 0.6%
497,980
+74,495
+18% +$3.08M
LGND icon
38
Ligand Pharmaceuticals
LGND
$5.88B
$19.1M 0.59%
147,821
+13,528
+10% +$1.51M
RP
39
DELISTED
RealPage, Inc.
RP
$18.9M 0.58%
342,129
-40,190
-11% -$2.27M
GDOT icon
40
Green Dot
GDOT
$755M
$18.4M 0.57%
251,089
-7,623
-3% -$526K
TPR icon
41
Tapestry
TPR
$29.9B
$18.2M 0.56%
388,854
-155,537
-29% -$7.48M
INXN
42
DELISTED
Interxion Holding N.V.
INXN
$18.2M 0.56%
290,916
-6,049
-2% -$387K
IART icon
43
Integra LifeSciences
IART
$1.37B
$18.1M 0.56%
+281,481
New +$17.4M
SUPN icon
44
Supernus Pharmaceuticals
SUPN
$2.73B
$18.1M 0.56%
+301,845
New +$15.6M
VG
45
DELISTED
Vonage Holdings Corporation
VG
$17.9M 0.55%
1,392,097
-195,169
-12% -$2.24M
MTZ icon
46
MasTec
MTZ
$23.7B
$17.7M 0.54%
348,723
+20,607
+6% +$995K
PODD icon
47
Insulet
PODD
$11.8B
$17.4M 0.53%
202,640
-7,516
-4% -$674K
SNV
48
DELISTED
Synovus
SNV
$17.2M 0.53%
324,779
-11,392
-3% -$606K
TSLA icon
49
Tesla
TSLA
$1.2T
$17M 0.52%
743,310
-10,650
-1% -$216K
TIF
50
DELISTED
Tiffany & Co.
TIF
$16.9M 0.52%
+128,449
New +$14.7M

Similar funds

Castleark Management's Q2 2018 Portfolio in Review

As of Q2 2018, Castleark Management held 462 positions worth $3.25B, up 2.9% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management withdrew a net $180M in Q2 2018, closing 93 positions and reducing 124 holdings. Its most notable exit was Monster Beverage, an estimated $28.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Castleark Management opened a new position in Union Pacific worth $36.7M.

  • Castleark Management's largest Q2 2018 buy was Union Pacific: 258,850 shares worth $36.7M.
  • Castleark Management added most to Costco in Q2 2018, an estimated $36.3M increase.
  • Castleark Management's biggest Q2 2018 reduction was Abiomed Inc, cutting an estimated $37.7M.
  • Castleark Management fully exited Monster Beverage in Q2 2018, selling an estimated $28.2M.
  • Castleark Management's ten largest holdings make up 17% of its $3.25B portfolio in Q2 2018.
  • Castleark Management opened 59 new positions and closed 93 in Q2 2018.
  • Castleark Management's portfolio value rose 2.9% quarter-over-quarter to $3.25B.

Based on Castleark Management's 13F filing for Q2 2018, filed 15 Aug 2018.